---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-033440"
form_type: "8-K"
ticker: "HTCR"
cik: "0001892322"
company_name: "HeartCore Enterprises, Inc."
filed_at: "2022-11-23T23:59:59+00:00"
generated_at: "2026-06-21T13:39:02.722944+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# HeartCore signs fifth Go IPO consulting deal with SBC Medical; $900k fees plus 2.7% warrant

## Summary
- HeartCore will receive $900,000 in initial fees under consulting agreement with SBC Medical.
- HeartCore also received a warrant for 2.7% of SBC Medical's fully diluted common stock, exercisable at $0.01 per share after IPO.
- Fifth Go IPO agreement in eight months; company assists Japanese firms with Nasdaq listing.
- Previously, HeartCore and SYLA amended their consulting deal, terminating a warrant in exchange for contingent cash payment.

## SEC filing metadata
- accession: 0001493152-22-033440
- form_type: 8-K
- ticker: HTCR
- cik: 0001892322
- company_name: HeartCore Enterprises, Inc.
- filed_at: 2022-11-23T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 1.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1892322/000149315222033440/0001493152-22-033440-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1892322/000149315222033440/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-033440
- JSON: https://secwatch.observer/filing/0001493152-22-033440.json
- Plain text: https://secwatch.observer/filing/0001493152-22-033440.txt

## Key facts
- Material Agreements
  HeartCore Enterprises, Inc. entered into SBC Consulting Agreement with SBC Medical Group, Inc. (SBC Medical) valued at $900,000 (effective 2022-11-18).
  - Action: entry
  - Counterparty: SBC Medical Group, Inc. (SBC Medical)
  - Value: $900,000
  - Effective: 2022-11-18
  source text: On November 18, 2022 (the “Effective Date”), the Company entered into a Consulting and Services Agreement (the “SBC Consulting Agreement”) by and between the Company and SBC Medical Group, Inc., a Japanese corporation (“SBC Medical”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1892322/000149315222033440/0001493152-22-033440-index.htm
- Material Agreements
  HeartCore Enterprises, Inc. entered into Rights Allotment Agreement with SYLA Technologies Co., Ltd. (SYLA) (effective 2022-11-09).
  - Action: entry
  - Counterparty: SYLA Technologies Co., Ltd. (SYLA)
  - Effective: 2022-11-09
  source text: On November 9, 2022, HeartCore Enterprises, Inc. (the “Company”) entered into the 9 th Stock Acquisition Rights Allotment Agreement (the “Rights Allotment Agreement”) by and between the Company and SYLA Technologies Co., Ltd. (“SYLA”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1892322/000149315222033440/0001493152-22-033440-index.htm
- Material Agreements
  HeartCore Enterprises, Inc. amended Amendment No. 2 to the Consulting Agreement with SYLA Technologies Co., Ltd. (SYLA) (effective 2022-11-15).
  - Action: amendment
  - Counterparty: SYLA Technologies Co., Ltd. (SYLA)
  - Effective: 2022-11-15
  source text: On November 15, 2022, the Company and SYLA entered into Amendment No. 2 to the Consulting Agreement (“Amendment No. 2”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1892322/000149315222033440/0001493152-22-033440-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.